Showing results (221-230 of 251) with videos related to
Sort By:
Pageof 26
International Journal of Cardiology|April 15, 2023
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoringCarlo Fumagalli, Francesca Bonanni, Matteo Beltrami, et al.ESC Heart Failure|November 27, 2023
Heart failure 'the cancer of the heart': the prognostic role of the HLM scorePaolo Severino, Massimo Mancone, Andrea D'Amato, et al.American Journal of Therapeutics|January 16, 2026
Therapeutic Advances in the Management of Cardiogenic ShockRadu Filipescu, Sean P Collins, Razvan I Radu, et al.Heart Failure Reviews|November 17, 2022
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunctionStefano Ghio, Mauro Acquaro, Piergiuseppe Agostoni, et al.ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.ESC Heart Failure|September 16, 2022
Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmasAlberto Palazzuoli, Marco Metra, Sean P Collins, et al.International Journal of Cardiology|March 7, 2018
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trialClaudio Moretti, Enrico Cerrato, Erika Cavallero, et al.Heart (British Cardiac Society)|May 26, 2012
Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patientsFabrizio D'Ascenzo, Davide Giacomo Presutti, Elisa Picardi, et al.International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.Pageof 26